Quince Therapeutics
QNCX
QNCX
67 hedge funds and large institutions have $523M invested in Quince Therapeutics in 2020 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 27 increasing their positions, 14 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0.48% less ownership
Funds ownership: 39.43% → 38.95% (-0.48%)
12% less capital invested
Capital invested by funds: $594M → $523M (-$71.6M)
Holders
67
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$11.3M | |
| 2 | +$7.8M | |
| 3 | +$5.73M | |
| 4 |
Capital Research Global Investors
Los Angeles,
California
|
+$4.5M |
| 5 |
BlackRock
New York
|
+$3.06M |
Top Sellers
| 1 | -$3.57M | |
| 2 | -$3.01M | |
| 3 | -$1.16M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$631K |
| 5 |
Goldman Sachs
New York
|
-$443K |